Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
Abstract Background: N6-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional RNA modification prevalent in eukaryotic cells. YT521-B homology domain…